OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53 | -39.8% | 17,000 | 0.0% | 0.01% | -37.5% |
| Q2 2023 | $88 | -2.2% | 17,000 | 0.0% | 0.01% | -11.1% |
| Q1 2023 | $90 | +87.5% | 17,000 | 0.0% | 0.01% | +80.0% |
| Q4 2022 | $48 | -99.9% | 17,000 | 0.0% | 0.01% | -37.5% |
| Q3 2022 | $71,000 | +4.4% | 17,000 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $68,000 | -19.0% | 17,000 | 0.0% | 0.01% | -12.5% |
| Q1 2022 | $84,000 | 0.0% | 17,000 | +41.7% | 0.01% | 0.0% |
| Q4 2021 | $84,000 | -89.8% | 12,000 | -90.0% | 0.01% | -90.5% |
| Q3 2018 | $826,000 | +53.0% | 120,001 | +50.0% | 0.08% | +42.4% |
| Q2 2018 | $540,000 | +3.6% | 80,011 | 0.0% | 0.06% | -3.3% |
| Q1 2018 | $521,000 | +46.3% | 80,011 | 0.0% | 0.06% | +45.2% |
| Q4 2017 | $356,000 | – | 80,011 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |